Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients

被引:40
作者
Cattaneo, Chiara [1 ]
Oberti, Margherita [1 ]
Skert, Cristina [2 ]
Passi, Angela [1 ]
Farina, Mirko [1 ]
Re, Alessandro [1 ]
Tozzi, Paola [1 ]
Borlenghi, Erika [1 ]
Rossi, Giuseppe [1 ]
机构
[1] Spedali Civil Brescia, Hematol, Pssa Spedali Civili 1, I-25123 Brescia, Italy
[2] Univ Brescia, Unit Blood Dis & Stem Cell Transplantat, Brescia, Italy
关键词
hemophagocytic syndrome; outcome of secondary hemophagocytic syndrome; hemophagocytic lymphohistiocytosis; hemophagocytosis; immune activation; MACROPHAGE ACTIVATION SYNDROME; JUVENILE IDIOPATHIC ARTHRITIS; OUTCOMES; PATHOGENESIS; DIAGNOSIS;
D O I
10.1002/hon.2314
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adult onset hemophagocytic lymphohistiocytosis (HLH) is a hyperinfiammatory syndrome, which can develop as a complication of many disorders. Early diagnosis is essential in order to avoid a fatal outcome. To confirm the diagnosis of acquired IILII made in a single institution series of adult patients with IILII-04 criteria, we applied the IlScore and evaluated prognostic factors associated with clinical outcome. The median age of 35 patients was 54 (range 17-81), M/F ratio was 20/15. In 26/35 (74.3%) patients, an underlying haematological disease was present (2 Multicentric Castleman Disease, 10 B-cell NonHodgkin Lymphoma INIILI and 14 T/NK-cell NHL); an autoimmune disorder was observed in four (11.4%) patients (one Still Disease, one undifferentiated connective tissue disease and two haemolytic anaemia); in five (14.3%), no underlying disease was identified. A concomitant infection by EBV was observed in 10 patients (28.6%), CMV in 8 (22.9%), HIM in 6 (17.1%) and HIV in 1 (2.9%). Hyperferritinemia, fever and splenomegaly were present in more than 90% of patients, whereas bone marrow hemophagocytosis in 51% of cases only. According to HScore, 34/35 patients had a >75% and 32/35 >93% probability of IILII. Four-year overall survival and IILII-free survival were 17.8% (CI 1.9-33.8) and 23.8% (CI 7.3-40.3), respectively. By multivariate analysis, presence of oedema and hyperbilirubinemia were predictors of death, whereas there was a statistically significant trend for viral infection as predictor of poor prognosis. B-NIIL diagnosis was confirmed as associated to a better prognosis in comparison with T/NK lymphoma (4-year 11FS 53.3% vs. 0%, p =0.09) and similar to other aetiologies. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:828 / 834
页数:7
相关论文
共 24 条
[1]   Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis [J].
Al Asad, Omar ;
Salam, Amir ;
Mannem, Siva ;
Ninan, Mary ;
Markowitz, Avi ;
Jana, Bagi .
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
[2]   Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide [J].
Arca, Marc ;
Fardet, Laurence ;
Galicier, Lionel ;
Riviere, Sebastien ;
Marzac, Christophe ;
Aumont, Cedric ;
Lambotte, Olivier ;
Coppo, Paul .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) :63-68
[3]   Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders [J].
Brisse, Ellen ;
Wouters, Carine H. ;
Matthys, Patrick .
CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (03) :263-280
[4]   Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens [J].
Chellapandian, DeepakBabu ;
Das, Rupali ;
Zelley, Kristin ;
Wiener, Susan J. ;
Zhao, Huaqing ;
Teachey, David T. ;
Nichols, Kim E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (03) :376-382
[5]   Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome [J].
Fardet, Laurence ;
Galicier, Lionel ;
Lambotte, Olivier ;
Marzac, Christophe ;
Aumont, Cedric ;
Chahwan, Doumit ;
Coppo, Paul ;
Hejblum, Gilles .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) :2613-2620
[6]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[7]  
Ho C., 2014, AM J CLIN PATHOL, V141, P62, DOI DOI 10.1309/AJCPMD5TJEFOOVBW
[8]   Hemophagocytic lymphohistiocytosis: pathogenesis and treatment [J].
Janka, Gritta E. ;
Lehmberg, Kai .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, :605-611
[9]   Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China [J].
Li, Fei ;
Li, Pu ;
Zhang, Rongyan ;
Yang, Ganping ;
Ji, Dexiang ;
Huang, Xianbao ;
Xu, Qian ;
Wei, Yanlin ;
Rao, Jia ;
Huang, Ruibing ;
Chen, Guoan .
MEDICAL ONCOLOGY, 2014, 31 (04)
[10]   Hemophagocytic Lymphohistiocytosis Clinical Analysis of 103 Adult Patients [J].
Li, Jing ;
Wang, Qian ;
Zheng, Wenjie ;
Ma, Jie ;
Zhang, Wei ;
Wang, Wenze ;
Tian, Xinping .
MEDICINE, 2014, 93 (02) :100-105